 |
 |
Hi...I just received these two drug alerts and am passing them on...#1) lists several drugs one of which has been mentioned here before... Baclofen (injectable) ........ and #2 mentions bextra ..used for arthritis pain..(last year, before it was "out on the shelf" as the dr put it, he gave me a two-month supply of samples...only took a couple of days worth and didn't take the rest as I felt "funny" on it..)......Joan Hartman 1) Sent: Monday, November 18, 2002 6:30 AM Subject: MedWatch - Nationwide alert concerning all injectable drugs prepa red by Urgent Care Pharmacy > MedWatch - The FDA Safety Information and Adverse Event Reporting Program The Food and Drug Administration (FDA) announced a nationwide alert concerning all injectable drugs prepared by Urgent Care Pharmacy of Spartanburg, South Carolina, based on the lack of assurance that their > products are sterile. Non-sterility of injectable products can represent a > serious hazard to health that could lead to life-threatening injuries and > death. FDA inspection of Urgent Care's facility revealed the firm failed to > have adequate controls to ensure necessary sterility, including the absence > of appropriate testing for potency and sterility prior to distribution. > FDA is aware that Urgent Care has distributed the following injectable drugs > to physicians, hospitals, clinics and consumers in Connecticut, Illinois, > Indiana, Kentucky, Louisiana, Massachusetts, Mississippi, New Hampshire, > North Carolina, South Carolina and Virginia: Baclofen, Betamethasone, Bimix > 30:1, (Phentolamine mesylate/papaverine), Clonidine, Estradiol, > Hydromorphone HCl, Fentanyl, Methylprednisole acetate, Morphine > Sulfate/Bupivacaine, Papaverine HCl, Super Trimix (Papaverine > HCl/phentolamine mesylate/prostaglandin), Testosterone cypionate, > Testosterone/Estradiol. > Read the MedWatch 2002 safety alert, including a link to the FDA Talk Paper regarding this alert, at: www.fda.gov/medwatch/SAFETY/2002/safety02.htm#inject 2) FDA Warns Painkiller Can Cause Serious Reactions The U.S. Food and Drug Administration has warned that a new painkiller called Bextra has been associated with potentially fatal skin diseases, and that anyone who develops a rash after taking it should stop the drug immediately. Since March, when Bextra sales first began, there have been about 20 reported cases of complications arising from the drug, including the skin diseases Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, and allergic reactions, the Associated Press reports. The FDA estimates that by the time the dangerous side effects were reported, about 800,000 to 1 million people had already begun taking Bextra, which is an anti-inflammatory used to treat arthritis and menstrual pain. Dr. Lawrence Goldkind, the agency's deputy director for painkillers, said there is less chance of a severe reaction occurring if users stop Bextra at the first hint of a rash. The FDA also said anyone allergic to drugs containing sulfa should not take Bextra. The FDA "Talk Paper" is at the following link ... www.fda.gov/bbs/topics/ANSWERS/2002/ANS01170.html ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn